Parallax Volatility Advisers, L.P. Natera, Inc. Transaction History

Parallax Volatility Advisers, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $1.66 Million - $2.76 Million	44,101 New	44,101 $2.76 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $1,265 - $2,004	45 New	45 $2,000
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $4,507 - $5,686	-45 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $457,958 - $637,149	-5,322 Reduced 99.16%	45 $5,000
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $490,919 - $667,440	5,367 New	5,367 $545,000
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $1,921 - $3,803	-156 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $2,935 - $4,517	156 New	156 $4,000
Q1 2018 May 15, 2018	SELL	$9.0 - $11.95 $42,714 - $56,714	-4,746 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.99 - $14.31 $42,666 - $67,915	4,746	4,746 $43,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.